Novavax, Inc. (NVAX) Latest Stock News & Headlines - Yahoo …
WEBGet the latest Novavax, Inc. (NVAX) stock news and headlines to help you in your trading and investing decisions.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What …
WEB3 days ago · The $739.47 million and $412.65 million estimates for the current and next fiscal years indicate changes of -24.8% and -44.2%, respectively. Novavax reported revenues of $415.48 million in the ...
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice …
WEB3 days ago · Ruxandra Draghia-Akli, MD, PhD brings more than 20 years of extensive clinical, corporate and global public health expertise to support Novavax's transition to an R&D-focused organization; Dr. Draghia-Akli will be integral in strategically evaluating the Company's pipeline and opportunities for its Matrix-M™ adjuvant and protein-based technology platform
Novavax Submits Application to U.S. FDA for Updated Protein …
WEBJun 14, 2024 · Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's...
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice …
WEB2 days ago · Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Ruxandra Draghia-Akli, MD, PhD, will join the Company in ...
Novavax shares soar on license deal with Sanofi at lofty valuation
WEBMay 10 (Reuters) - Novavax (NVAX.O) on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi (SASY.PA) for its COVID-19 vaccine in exchange for a stake that valued...
Novavax Inc (NVAX) Stock Price & News - Google Finance
WEBGet the latest Novavax Inc (NVAX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated …
WEBThe FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula.
Novavax taps J&J, Merck alum as new R&D head
WEB2 days ago · Novavax taps J&J, Merck alum as new R&D head. Dr. Ruxandra Draghia-Akli is Novavax's new head of research and development. Gaithersburg’s Novavax Inc. (NASDAQ: NVAX) has named a new head of ...
Novavax (NVAX) Biggest Surge Since 2009 Burns Shorts for $255 …
WEBMay 10, 2024 · Novavax Inc.’s record one-day gain is forcing some short sellers betting against the stock to exit their positions at a loss.
Skip to content